Profil
Doug Mendenhall worked as the Chief Scientific Officer at Patheon, Inc. from 2009 to 2010.
He received his undergraduate degree from the University of Washington and his graduate and doctorate degrees from the University of Kansas.
Anciens postes connus de Doug Mendenhall
| Sociétés | Poste | Fin |
|---|---|---|
| PATHEON, INC. | Directeur Technique/Scientifique/R&D | 15/04/2010 |
Formation de Doug Mendenhall
| University of Kansas | Doctorate Degree |
| University of Washington | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Patheon, Inc.
 Patheon, Inc. Pharmaceuticals: MajorHealth Technology Patheon, Inc. provides drug development and manufacturing services to global pharmaceutical, biotechnology and specialty pharmaceutical companies. It operates through two segments: Commercial Manufacturing Outsourcing and Pharmaceutical Development Services. The Commercial Manufacturing Outsourcing segment manufactures prescription products in sterile dosage forms as well as solid and liquid conventional dosage forms. The Pharmaceutical Development Services segment provides a broad range of development services, including solid and sterile dosage forms. The company operates through four market segments: Biologics, Emerging Pharma, Generics and Large Pharma. Patheon was founded in 1974 and is headquartered in Mississauga, Canada. | Health Technology |